Narrow Results

INDONESIA – Quintiles expands patient access for clinical trials to Indonesia.

JAPAN – Legacy Healthcare announces breakthrough clinical results in hair re-growth.

SINGAPORE – iNova Pharmaceuticals relocates Regional HQ to Singapore as part of Asia-centric reorganization.

AUSTRALIA – Silencing the bird flu gene: scientists prep live hen trials.

AUSTRALIA – Helsinn grants Specialised Therapeutics Australia (STA) rights to Anamorelin, treat cachexia-anorexia.

NORTH AMERICA – To survive, genes pick up new skills.

NORTH AMERICA – Phase III study evaluates two investigational hormone-releasing IUDs for prevention of pregnancy for up to three years.

NORTH AMERICA – Agilent Technologies introduces SureDesign.

NORTH AMERICA – Progress made towards production of biosimilar products in tobacco plants.

NORTH AMERICA – FDA approves Aerospan for asthma.

EUROPE – New technology offers improved chances for couples undergoing IVF.

EUROPE – Phase IIa Laquinimod trial results show positive data for potential use in active Crohn's Disease.

EUROPE – Pfizer donates vials of Factor IX to the World Federation of Hemophilia.

EUROPE – nViso gets research grant to study 3D facial imaging technology for healthcare applications.

EUROPE – New evidence-based 3D cell culture web portal launched by Reinnervate Ltd.

EUROPE – The social side of vaccine effectiveness.

Climate change and emerging pests and diseases may negatively affect coffee yields and revenues in Ethiopian regions at low altitudes. Hence, the relocation of coffee farms to regions at higher altitudes has been suggested in order to assure sustainability and resilience for Ethiopian coffee production. In this paper, we study how sunk establishment costs, uncertain net returns and policy-induced incentives may affect the timing and value of a coffee farm relocation. This is done by developing a real-options model taking into account the relevant drivers of the farmer’s decision to relocate. We then present an empirical analysis examining a hypothetical relocation. We show that relocation is a rather attractive opportunity even though the presence of volatile net returns and relatively high establishment costs may induce its postponement. Thus, we determine the optimal amount of subsidy needed in order to foster the relocation process.